scholarly journals Examination of the influence of cedar fragrance on cognitive function and behavioral and psychological symptoms of dementia in Alzheimer type dementia

2020 ◽  
Vol 40 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Yuya Takahashi ◽  
Sho Shindo ◽  
Takashi Kanbayashi ◽  
Masahiro Takeshima ◽  
Aya Imanishi ◽  
...  
Keyword(s):  
Cognitive Function ◽  
Psychological Symptoms ◽  
Alzheimer Type ◽  
Alzheimer Type Dementia ◽  
Behavioral And Psychological Symptoms

scholarly journals Correlation between Behavioural and Psychological Symptoms of Alzheimer Type Dementia and Plasma Homocysteine Concentration

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
Zhanjie Zheng ◽  
Jindong Wang ◽  
Lei Yi ◽  
Hui Yu ◽  
Lingli Kong ◽  
...  
Keyword(s):  
Psychological Symptoms ◽  
Plasma Homocysteine ◽  
Healthy Controls ◽  
Alzheimer Type ◽  
Homocysteine Concentration ◽  
Alzheimer Type Dementia ◽  
Plasma Homocysteine Concentration ◽  
First Time ◽  
The Relationship ◽  
Behavioral And Psychological Symptoms

The relationship between plasma homocysteine and behavioral and psychological symptoms of dementia (BPSD) has not been specifically investigated in previous research. In this study, we compared plasma homocysteine (Hcy) among 40 Alzheimer’s disease (AD) patients with BPSD, 37 AD patients without BPSD, and 39 healthy controls. Our results evidenced that the plasma homocysteine levels in AD patients with BPSD and without BPSD were higher than healthy controls and that the plasma homocysteine concentration in AD patients with BPSD was the highest among the three groups. Significant correlation between plasma homocysteine concentration and cognitive decline and duration of dementia was observed, but there was no correlation between BPSD and cognitive dysfunction or duration of dementia. In conclusion, this study showed for the first time that BPSD were associated with plasma homocysteine concentration in Alzheimer's dementia, and the results supported that hyperhomocysteine may take part in the pathogenesis of BPSD.

Effect of Risperidone on Behavioral and Psychological Symptoms and Cognitive Function in Dementia

2001 ◽  
Vol 62 (11) ◽  
pp. 894-900 ◽  
Author(s):  
Michael K. Rainer ◽  
Andreas J. Masching ◽  
Michael G. Ertl ◽  
Eva Kraxberger ◽  
Manfred Haushofer
Keyword(s):  
Cognitive Function ◽  
Psychological Symptoms ◽  
Behavioral And Psychological Symptoms

Hormone Treatments for Behavioral and Psychological Symptoms of Dementia

2000 ◽  
Vol 12 (S1) ◽  
pp. 291-295 ◽  
Author(s):  
Gary W. Small
Keyword(s):  
Cognitive Function ◽  
Postmenopausal Women ◽  
Older Persons ◽  
Laboratory Tests ◽  
Psychological Symptoms ◽  
Endocrine Disorders ◽  
Mood Symptoms ◽  
Treatment Of Depression ◽  
Cognitively Intact ◽  
Behavioral And Psychological Symptoms

Several hormones have the potential for influencing the behavioral and psychological symptoms of dementia (BPSD). Endocrine disorders stemming from the thyroid and parathyroid glands, for example, can be identified through screening laboratory tests, and if the underlying abnormalities are treated, symptoms may improve. The hormone that has received the greatest attention, however, regarding its potential for treating both cognitive and mood symptoms in older persons is estrogen. Recent data suggest that estrogen may facilitate treatment of depression in cognitively intact postmenopausal women and may decrease the risk of Alzheimer's disease in postmenopausal women. In part because testosterone is converted to estrogen in men, recent studies suggest that treating hypogonadal men with testosterone may improve their cognitive function.

Sign in / Sign up

Export Citation Format

Share Document